Consolidated Statements of Stockholders' Deficit - USD ($) $ in Thousands	Total	Common Stock	Additional Paid-In Capital	Accumulated Other Comprehensive Income	Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2022		187,906,000
Beginning balance at Dec. 31, 2022	$ (294,597)	$ 1,879	$ 1,158,118	$ 26	$ (1,454,620)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	(226,539)				(226,539)
Other comprehensive income (loss)	1,311			1,311
Exercise of stock options, net (in shares)		1,276,000
Exercise of stock options, net	6,114	$ 13	6,101
Vesting of restricted stock units (in shares)		1,276,000
Vesting of restricted stock units	0	$ 13	(13)
Shares withheld for taxes for vesting of restricted stock units (in shares)		(59,000)
Shares withheld for taxes for vesting of restricted stock units	$ (370)	$ (1)	(369)
Employee stock purchase plan sales (in shares)	338,000	338,000
Employee stock purchase plan sales	$ 2,596	$ 4	2,592
Exercise of warrants (in shares)		14,997,000
Exercise of warrants	0	$ 150	(150)
Issuance of shares to directors in lieu of cash retainer (in shares)		37,000
Issuance of shares to directors in lieu of cash retainer	342		342
Stock-based compensation expense	55,615		55,615
Ending balance (in shares) at Dec. 31, 2023		205,771,000
Ending balance at Dec. 31, 2023	(455,528)	$ 2,058	1,222,236	1,337	(1,681,159)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	(88,881)				(88,881)
Other comprehensive income (loss)	(416)			(416)
Exercise of stock options, net (in shares)		548,000
Exercise of stock options, net	2,280	$ 5	2,275
Vesting of restricted stock units (in shares)		1,902,000
Vesting of restricted stock units	0	$ 19	(19)
Shares withheld for taxes for vesting of restricted stock units (in shares)		(94,000)
Shares withheld for taxes for vesting of restricted stock units	$ (689)	$ (1)	(688)
Employee stock purchase plan sales (in shares)	412,000	412,000
Employee stock purchase plan sales	$ 1,853	$ 4	1,849
Issuance of shares to directors in lieu of cash retainer (in shares)		4,000
Issuance of shares to directors in lieu of cash retainer	34		34
Stock-based compensation expense	$ 65,413		65,413
Ending balance (in shares) at Dec. 31, 2024	208,543,000	208,543,000
Ending balance at Dec. 31, 2024	$ (475,934)	$ 2,085	1,291,100	921	(1,770,040)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	263,861				263,861
Other comprehensive income (loss)	(883)			(883)
Exercise of stock options, net (in shares)		1,487,000
Exercise of stock options, net	7,879	$ 15	7,864
Vesting of restricted stock units (in shares)		2,796,000
Vesting of restricted stock units	0	$ 28	(28)
Shares withheld for taxes for vesting of restricted stock units (in shares)		(142,000)
Shares withheld for taxes for vesting of restricted stock units	$ (1,062)	$ (1)	(1,061)
Employee stock purchase plan sales (in shares)	369,000	369,000
Employee stock purchase plan sales	$ 2,298	$ 4	2,294
Issuance of shares to directors in lieu of cash retainer (in shares)		7,000
Issuance of shares to directors in lieu of cash retainer	59		59
Stock-based compensation expense	85,137		85,137
Reclassification of equity awards to share-based liability	(2,558)		(2,558)
Remeasurement of share-based liability	$ 2,050		2,050
Ending balance (in shares) at Dec. 31, 2025	213,060,000	213,060,000
Ending balance at Dec. 31, 2025	$ (119,153)	$ 2,131	$ 1,384,857	$ 38	$ (1,506,179)